Carcinoma Squamous Cell
📧 Sign up to get email alerts when something new happens for Carcinoma Squamous Cell.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2021-11-29EMA Application withdrawn: Zynyz (retifanlimab) — Incyte Biosciences Distribution B.V.
The EMA has withdrawn the application for Zynyz (retifanlimab) by Incyte Biosciences Distribution B.V. for anus neoplasms and squamous cell …
-
EMA withdrawal · 2009-07-23EMA Application withdrawn: Contusugene Ladenovec Gendux — Gendux Molecular Limited
The EMA withdrawal of the application for Contusugene Ladenovec Gendux by Gendux Molecular Limited.